Literature DB >> 30874626

The benefits of neuroinflammation for the repair of the injured central nervous system.

Heather Y F Yong1, Khalil S Rawji1, Samira Ghorbani1, Mengzhou Xue2, V Wee Yong3.   

Abstract

Inflammation of the nervous system (neuroinflammation) is now recognized as a hallmark of virtually all neurological disorders. In neuroinflammatory conditions such as multiple sclerosis, there is prominent infiltration and a long-lasting representation of various leukocyte subsets in the central nervous system (CNS) parenchyma. Even in classic neurodegenerative disorders, where such immense inflammatory infiltrates are absent, there is still evidence of activated CNS-intrinsic microglia. The consequences of excessive and uncontrolled neuroinflammation are injury and death to neural elements, which manifest as a heterogeneous set of neurological symptoms. However, it is now readily acknowledged, due to instructive studies from the peripheral nervous system and a large body of CNS literature, that aspects of the neuroinflammatory response can be beneficial for CNS outcomes. The recognized benefits of inflammation to the CNS include the preservation of CNS constituents (neuroprotection), the proliferation and maturation of various neural precursor populations, axonal regeneration, and the reformation of myelin on denuded axons. Herein, we highlight the benefits of neuroinflammation in fostering CNS recovery after neural injury using examples from multiple sclerosis, traumatic spinal cord injury, stroke, and Alzheimer's disease. We focus on CNS regenerative responses, such as neurogenesis, axonal regeneration, and remyelination, and discuss the mechanisms by which neuroinflammation is pro-regenerative for the CNS. Finally, we highlight treatment strategies that harness the benefits of neuroinflammation for CNS regenerative responses.

Entities:  

Mesh:

Year:  2019        PMID: 30874626      PMCID: PMC6804643          DOI: 10.1038/s41423-019-0223-3

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  117 in total

Review 1.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

2.  Requirement of myeloid cells for axon regeneration.

Authors:  Benoit Barrette; Marc-André Hébert; Mohammed Filali; Kathleen Lafortune; Nicolas Vallières; Geneviève Gowing; Jean-Pierre Julien; Steve Lacroix
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

Review 3.  Neuro-immune crosstalk in CNS diseases.

Authors:  M Kerschensteiner; E Meinl; R Hohlfeld
Journal:  Neuroscience       Date:  2008-09-13       Impact factor: 3.590

4.  Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord.

Authors:  Kristina A Kigerl; John C Gensel; Daniel P Ankeny; Jessica K Alexander; Dustin J Donnelly; Phillip G Popovich
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

5.  TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord.

Authors:  Antje Kroner; Andrew D Greenhalgh; Juan G Zarruk; Rosmarini Passos Dos Santos; Matthias Gaestel; Samuel David
Journal:  Neuron       Date:  2014-08-14       Impact factor: 17.173

Review 6.  Multiple sclerosis.

Authors:  Alan J Thompson; Sergio E Baranzini; Jeroen Geurts; Bernhard Hemmer; Olga Ciccarelli
Journal:  Lancet       Date:  2018-03-23       Impact factor: 79.321

7.  Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.

Authors:  Jean-Philippe Michaud; Maxime Hallé; Antoine Lampron; Peter Thériault; Paul Préfontaine; Mohammed Filali; Pascale Tribout-Jover; Anne-Marie Lanteigne; Rachel Jodoin; Christopher Cluff; Vincent Brichard; Rémi Palmantier; Anthony Pilorget; Daniel Larocque; Serge Rivest
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-15       Impact factor: 11.205

Review 8.  Microglia in Alzheimer's disease: A multifaceted relationship.

Authors:  Ayman ElAli; Serge Rivest
Journal:  Brain Behav Immun       Date:  2015-08-04       Impact factor: 7.217

9.  IGF-I and microglia/macrophage proliferation in the ischemic mouse brain.

Authors:  Steven L O'Donnell; Terra J Frederick; J Kyle Krady; Susan J Vannucci; Teresa L Wood
Journal:  Glia       Date:  2002-07       Impact factor: 7.452

Review 10.  Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

Authors:  V Wee Yong
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

View more
  41 in total

1.  Harnessing the Benefits of Neuroinflammation: Generation of Macrophages/Microglia with Prominent Remyelinating Properties.

Authors:  Manoj Kumar Mishra; Khalil S Rawji; Michael B Keough; Janson Kappen; Reza Dowlatabadi; Hans J Vogel; Sameeksha Chopra; Félix Distéfano-Gagné; Antoine Dufour; David Gosselin; V Wee Yong
Journal:  J Neurosci       Date:  2021-03-12       Impact factor: 6.167

Review 2.  Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function.

Authors:  Alanna G Spiteri; Claire L Wishart; Roger Pamphlett; Giuseppe Locatelli; Nicholas J C King
Journal:  Acta Neuropathol       Date:  2021-12-01       Impact factor: 17.088

Review 3.  Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis.

Authors:  Heather Y F Yong; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2021-11-03       Impact factor: 42.937

4.  Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels.

Authors:  Carlos Camara-Lemarroy; Luanne Metz; Jens Kuhle; David Leppert; Eline Willemse; David Kb Li; Anthony Traboulsee; Jamie Greenfield; Graziela Cerchiaro; Claudia Silva; V Wee Yong
Journal:  Mult Scler       Date:  2022-07-18       Impact factor: 5.855

Review 5.  APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Authors:  Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg
Journal:  Mol Neurodegener       Date:  2022-09-24       Impact factor: 18.879

6.  Longitudinal monitoring of microglial/macrophage activation in ischemic rat brain using Iba-1-specific nanoparticle-enhanced magnetic resonance imaging.

Authors:  Laurel O Sillerud; Yirong Yang; Lisa Y Yang; Kelsey B Duval; Jeffrey Thompson; Yi Yang
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-22       Impact factor: 6.200

7.  Neuregulin-1 beta 1 is implicated in pathogenesis of multiple sclerosis.

Authors:  Hardeep Kataria; Christopher G Hart; Arsalan Alizadeh; Michael Cossoy; Deepak K Kaushik; Charles N Bernstein; Ruth Ann Marrie; V Wee Yong; Soheila Karimi-Abdolrezaee
Journal:  Brain       Date:  2021-02-12       Impact factor: 13.501

Review 8.  Microbial Infections Are a Risk Factor for Neurodegenerative Diseases.

Authors:  Sarah K Lotz; Britanie M Blackhurst; Katie L Reagin; Kristen E Funk
Journal:  Front Cell Neurosci       Date:  2021-07-07       Impact factor: 5.505

Review 9.  miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases.

Authors:  Jinying Xu; Yangyang Zheng; Yulin Li; Guangfan Chi; Liangjia Wang; Yining Liu; Xishu Wang
Journal:  Cell Mol Neurobiol       Date:  2021-04-22       Impact factor: 4.231

Review 10.  Mechanisms of Drug Resistance in the Pathogenesis of Epilepsy: Role of Neuroinflammation. A Literature Review.

Authors:  Elena D Bazhanova; Alexander A Kozlov; Anastasia V Litovchenko
Journal:  Brain Sci       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.